Fungi News

The EUCAST AFST have recently published v 8.0 of the routine and extended quality control ranges and targets for MIC determination in yeasts, moulds and dermatophytes, including revised QC ranges for…

M.C. Arendrup et al. / Clinical Microbiology and Infection 32 (2026) 56—61.
EUCAST guidance on how to interpret EUCAST MICs against C. auris has been released in CMI as open access article.

Download…

A minor error was corrected in in table 1, page 13 of the EDef 10.2 document, the new version (10.3) has been published.

The following ECOFFs and breakpoints for antifungal agents have been established or revised and are...

How to interpret MICs of amphotericin B, echinocandins and flucytosine

against Candida...

EUCAST AFST recently proposed new breakpoints for amphotericin B, three echinocandins and...

Public consultation on breakpoints for Candida auris 2025-03-06 - 04-17.

The breakpoint table for antifungal agents (V. 11) and the overview of clinical breakpoints...

The anidulafungin and micafungin rationale documents updated by the EUCAST AFST subcommittee (25...

Twenty Years in EUCAST Anti‑Fungal Susceptibility Testing: Progress & Remaining...

The Warning pertains to the following AST methods for amphotericin B and C. auris.

Etest,...

The AFST published the first Rationale Document on Rezafungin.